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 Abstract 
 Background: Dementia is a neurodegenerative disease whose prevalence is rising, and the 
need for assistance to patients becomes indispensable. The different types of dementia and 
their treatments have been widely studied; however, the health status of caregivers also re-
quires our attention.  Objective: The aim of our research was to evaluate whether caregivers 
of patients with dementia consume more medications than the general population, indicating 
underlying pathologies.  Methods: A total of 91 caregivers of dementia patients were inter-
viewed and their answers were compared with those from a control group of 48 people, tak-
ing into account demographic data, characteristics of patients and caregivers, pharmacolog-
ical and nonpharmacological treatments and burden.  Results: Caregivers showed a 
significantly higher consumption of anxiolytics, antidepressants and antiplatelets (22.3, 13.2 
and 11%, respectively) than the control group (14.6, 0 and 0%, respectively). Moreover, 45.1% 
of the caregivers used nonpharmacological therapies compared with 6.2% of the control 
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group. There was a tendency to take more medications in those caregivers suffering from 
burden and those who had to take care of patients with behavioral changes.  Conclusion: 
Caregivers of dementia patients need more pharmacological and nonpharmacological thera-
pies. They are a risk group that needs better care from the health system.  
 © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 The prevalence of diseases associated with age, such as dementia, is rapidly increasing 
because of the population ageing. Between 25 and 30% of those who are 85 years and older 
have some degree of cognitive impairment. In Spain, the prevalence of this disease is esti-
mated to be higher than 600,000 people  [1] .
 Due to the degenerative nature of dementia, alterations in cognitive, functional and social 
spheres gradually occur, generating an increasing dependence, which results in the need for 
a caregiver’s intervention. For our project, we defined ‘caregiver’ as a family member respon-
sible for the care of others, without receiving any compensation. In the USA, more than 15 
million family members, friends and neighbors provided care without payment to Alzheimer’s 
disease patients in 2014  [2] . The constant support and dedication that carers provide to 
patients with dementia seriously affects their own quality of life  [3] . 
 Because of that impact, one of the first manifestations is evident in the psychological state 
of the caregiver, including frequent stress, as shown in several articles  [4, 5] . In fact, providing 
care to patients with Alzheimer’s disease is a common model for studying stress impact  [6] . 
Due to this high stress level, these family caregivers are at a higher risk of becoming physi-
cally or mentally diseased  [7] , leading, in a considerable number of occasions, to a state of 
depression, as reported by several studies  [5, 6, 8–13] .
 But it is not only the psychological aspect which is altered, because, as several studies 
have been commissioned to demonstrate, the condition of caregivers of dementia patients is 
associated with an increased incidence of psychosomatic effects, such as increased cardiovas-
cular risk  [14–18] , coagulation problems  [15, 19] , chronic stress  [20] , sleep problems  [19, 21] 
and decreased immune function, leading to increased risk of infection (primarily of the upper 
respiratory tract) and recovery time thereof  [22–24] .
 So, it is clear that caregivers of patients with dementia are highly physically and mentally 
burdened, being this burden higher than that felt by other caregivers  [7] . Furthermore, this 
burden leads to acute and chronic illness, making caregivers just as ill as the person whom 
they are taking care of  [25, 26] . For all these reasons, the caregiver status has been linked to 
an increased risk of death  [19, 20, 27–29] .
 The aim of this study was to assess whether caregivers of dementia patients consume 
more drugs than the general population, indicating underlying pathologies these caregivers 
might be suffering.
 Materials and Methods 
 Study Design and Participants  
 This is a cross-sectional study that was carried out in Madrid from February to August 
2013 based on an oral survey directed to a group of cases and controls. A sample of 91 cases 
was selected based on the following inclusion criteria: taking care of a family member diag-
nosed with dementia, not receiving remuneration for it and being the primary caregiver. 
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 Case finding was conducted in the waiting room of the Memory Unit of the Neurology 
Service at the Hospital Universitario La Princesa, in the Elderly Day Centre ‘El Bosque’ in 
Madrid and among members of the association of relatives of patients with Alzheimer disease 
of Parla (Madrid). As a reference, a group of 48 controls was chosen randomly within the 
Madrid population, specifically among medicine students’ relatives and people who were 
accompanying patients without dementia to the Hospital Universitario La Princesa. These 
controls had to meet the following requirements: same sex as the corresponding case and 
within an age range of ±5 years (1 control for every 2 cases), not having a first-degree relative 
(father, mother, siblings and children) with dementia, not taking care of ill people and not 
being cared for by anyone. As no previous data were available, we did a pilot study and no 
formal sample size calculation was performed. 
 Determining Variables 
 The variables analyzed in the study were collected in a single interview under the same 
conditions for both the cases and controls. This survey included demographics data, such as 
age, sex, nationality and educational level as well as information about their caregiving role 
and information related to the possible pathologies suffered by participants and drug use for 
their treatment.
 Caregivers were also asked about how long they had been taking care of the patient and 
the time dedicated per day, kinship, if they were in charge of someone else, if they had a job, 
if they received external help (home assistant, other family member, etc.), as well as whether 
they had received any informative session about the disease and its care. In addition, the 
survey included some questions about the patient, such as age, the duration of time the patient 
has been suffering from dementia and whether the patient had behavioral problems (based 
on the caregiver’s interview), divided into positive (irritability, restlessness and/or 
aggression) and negative symptoms (apathy and/or sadness). Finally, the respondents were 
asked if they received some kind of nonpharmacological support (psychologist, therapist, 
social worker, support of an association of relatives of patients, etc.) and whether they felt 
burdened (data obtained from the clinic interview with the caregiver).
 The information about behavioral changes in patients could not be evaluated for every 
participant because of modifications that took place during the process of our study. These 
modifications were made to improve the quality of our project, based on the relevance of 
information, according to the literature  [7] .
 Statistical Analysis 
 Survey data were tabulated using Microsoft Excel, which served for descriptive statistics. 
The quantitative variables are presented as average and standard deviation and qualitative 
variables are given as percentages. The comparison between cases and controls was performed 
with the χ 2 test. SPSS 22.0 was used, and results were considered statistically significant when 
p < 0.05.
Features Cases (n = 91) Controls (n = 48)
Age, years 67.96 ± 12.61 66.45 ± 14.01
Sex
Men
Women
36 (39.56%)
55 (60.43%)
19 (39.58%) 
29 (60.42%)
Spanish nationality 90 (98.90%) 48 (100%)
Higher education 36 (39.6%) 13 (27.1%)
 Table 1.  Demographic data 
(average ± standard deviation or 
percentage)
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 Ethical Aspects 
 All interviewees were thoroughly explained the project and indicated that they volunteer 
in participating. If they agreed to collaborate, the questionnaire was administered anony-
mously, maintaining data confidentiality at any time and without collecting identification 
data, so no written consent was requested. 
 The project was approved by the Ethics Committee for Clinical Research of the Hospital 
Universitario La Princesa.
 Results 
 Numerical values for age and sex in cases and controls are similar according to the 
selection criteria ( table 1 ). The participants have an age of around 67–68 years and there is 
a higher percentage of women (60.43%). Most cases (98.90%) and all controls (100%) have 
Spanish nationality, and 39.6 and 27.1%, respectively, have a higher education. 
 An important aspect in studying the characteristics of caregivers and patients with 
dementia is the time spent taking care of the diseased relative (averaging 5.06 ± 3.87 years). 
The kinship of the caregiver was also asked, and we found a higher percentage of wives (33%) 
and husbands (33%), followed by sons and daughters (26.4%). Other minority groups are: 
nephew/niece (3.3%), sister-in-law (2.2%) and sister/brother (2.2%). Most caregivers 
(83.5%) reported to spend more than 20 h a week caring for the patient; they did not have 
anyone else in charge (85.7%) and they did not work (72.5%), but only 3.3% stopped working 
to care for the patient [19 (20.9%) participants did not answer this last question]. The 
remaining group of caregivers spent between 7 and 20 h (8.8%) or less than 7 h (6.6%) per 
week taking care of the patient [1 (1.1%) person did not answer this question]. Less than 40% 
of the cases (38.5%) received an informative session about the disease and its care [unan-
swered: 2 (2.2%)].
 Table 2. Number (and percentage) of cases and controls receiving drugs from each of the drug groups 
Pharmacological group Cases (n = 91) Controls (n = 48) p
Analgesics 20 (22.2%) 7 (14.6%) 0.281
Antihypertensive 37 (40.7%) 20 (41.7%) 0.376
Cholesterol-lowering drugs 23 (25.3%) 9 (18.8%) 0.385
Anxiolytics 22 (24.2%) 1 (2.1%) 0.001
Antidepressants 12 (13.2%) 0 0.008
Osteoporosis medication 8 (8.8%) 5 (10.4%) 0.754
Gastroprotectives 17 (18.7%) 12 (25.0%) 0.249
Antiplatelets 10 (11.0%) 0 0.017
Thyroid hormone 4 (4.4%) 2 (4.2%) 0.950
Anti-COPD 5 (5.5%) 6 (12.5%) 0.146
Antidiabetics 9 (9.9%) 7 (14.6%) 0.410
Prostate drugs 4 (4.4%) 2 (4.2%) 0.950
Anticoagulants 4 (4.4%) 6 (12.5%) 0.079
Others 20 (22%)
(eyedrops, eardrops, antiarrhythmics, 
antiepileptics, antihistamines, 
magnesium, vitamin B and D, 
antipsychotics, antirheumatic, 
gallstone solvent, antimuscarinic)
10 (20.8%)
(antiarrhythmics, hypouricemics, 
laxatives, oral contraceptives, 
antipsoriatics, antiepileptics, cataracts 
medications and prostate cancer 
medications)
0.891
No drugs 17 (18.7%) 9 (18.8%) 0.992
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 External support was considered an important aspect in the process of caring, but 21.97% 
did not receive it, and 1 (1.1%) person did not answer this question. The most frequent 
support came from day centers (35.2%), other family members (27.47%), home assistants 
(21.97%) and associations of relatives of patients (16.9%). The average patient age was 
around 78.32 ± 7.48 years, with an average duration of suffering from the disease of 4.76 ± 
3.20 years. The behavioral symptoms were only evaluated in 61 cases; of those, 57.38% of the 
cared patients reported positive symptoms (irritability, restlessness and/or aggression), 
19.67% reported negative symptoms (apathy and/or sadness) and 14.75% reported both, 
while 30 cases did not answer this question.
 More than 80% of cases and controls take some drug ( table 2 ). Consumption of anxio-
lytics, antidepressants and antiplatelets was higher in the case group (24.2, 13.2 and 11%, 
respectively) than in the controls (2.1, 0 and 0%, respectively). The nonpharmacological 
treatments of the case and control groups are represented in  table 3 . Less than 7% of the 
controls require this kind of therapies, compared with around half of the cases. It was also 
found that nearly 30% of the cases were supported by an association. 
 We also studied the feeling of burden; although only 82 cases and 38 controls answered 
this question, 61 cases (67%) responded affirmatively versus none of the controls (p < 0.001). 
There was a trend towards a higher percentage of use of analgesics, antidepressants and 
anxiolytics among the cases that felt burdened (23.3% took analgesics and 31.1% anxiolytics) 
compared to the nonburdened cases (19% used analgesics and 4.8% anxiolytics), but statis-
tical significance was only reached for anxiolytics ( table 4 ). Caregivers of patients with 
positive symptoms for the behavioral changes used more analgesics, antidepressants and 
anxiolytics (only significant for anxiolytics), but less antiplatelets ( table 5 ).
 If we relate the consumption of drugs with receiving no assistance from associations or 
psychologists, we can find a few interesting differences. For example, there is a notably higher 
consumption of anxiolytics (23.1 vs. 25.4%), analgesics (30.8 vs. 17.7%), antihypertensives 
(50 vs. 34.9%) and statins (36.4 vs. 22.2%) among those seeking help from associations/
Cases (n = 91) Controls (n = 48) p
Psychologist 16 (17.6%) 0 0.004
Physiotherapist 6 (6.6%) 2 (4.2%) 0.485
Social worker 15 (16.5%) 1 (2.1%) 0.021
Support of an association 26 (28.6%) 0 0.000
Others 1 (1.1%) 0 0.466
None 49 (53.8%) 45 (93.8%) 0.000
No answer 1 (1.1%) 0 1.000
 Table 4. Relationship between subjective burden and consumption of analgesics, anxiolytics, antidepressants 
and antiplatelets in cases
Drugs Burden
 yes (n = 61) no (n = 21) no answer (n = 9) p
Analgesics 14 (23.3%) 4 (19.0%) 2 (22.2%) 0.921
Anxiolytics 19 (31.1%) 1 (4.8%) 2 (22.2%) 0.05
Antidepressants 9 (14.8%) 2 (9.5%) 1 (11.1%) 0.814
Antiplatelets 6 (9.8%) 3 (14.3%) 1 (11.1%) 0.854
 Table 3. Number (and 
percentage) of cases and controls 
receiving nonpharmacological 
treatments 
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psychologists compared with those who do not. By contrast, more cases receiving no support 
from associations did not take any drug (22.2 vs. 15.38%).
 We also analyzed the relationship between some demographic data and drug consumption, 
i.e. between the gender of caregivers and four groups of drugs (analgesics, anxiolytics, anti-
depressants and antiplatelets), usually getting higher percentages among female caregivers, 
except for antiplatelets (female vs. male: 24.1 vs. 19.4%, 36.4 vs. 5.6%, 16.4 vs. 8.3% and 7.3 
vs. 16.7%, respectively). Anxiolytics are the only group of drugs that achieved a statistically 
significant difference.
 By analyzing the relationship between the same groups of drugs and having or not a 
higher education, we noticed that only analgesics and anxiolytics achieved a significant 
difference, i.e. a higher consumption among caregivers with a higher education (8.3 vs. 30.9% 
and 8.3 vs. 34.5%, respectively).
 Discussion 
 Our results show that there are statistically significant differences in the consumption of 
antidepressants, anxiolytics and antiplatelets among caregivers of patients with dementia 
and noncaregivers. Considering the study of the consumption of antidepressants and anxio-
lytics, two authors have succeeded in demonstrating an association between this consumption 
and caregiving  [30, 31] . Clipp and George  [30] compared the use of psychotropic drugs in a 
group of caregivers with the prevalence of consumption in the general population showing a 
significant difference. Camargos et al.  [31] found that the caregivers of patients with dementia 
consumed more benzodiazepines, antidepressants and psychotropic drugs than caregivers of 
patients without dementia.
 It is notable that the use of these drugs is higher in our study than in previous ones. The 
reason could be because most of the interviews with caregivers were carried out in a hospital 
environment, increasing the probability of an advanced stage of dementia. 
 In our study, the comparison was made with a control group which was similar regarding 
age and sex, and, unlike the two studies mentioned above, we did not only focus on the asso-
ciation of psychotropic drugs but also analyzed all kinds of drugs, demonstrating, among 
others, a statistically significant association between antiplatelet drugs and caring for patients 
with dementia. This association may probably be related to an increased cardiovascular risk 
in this group; however, we were unable to demonstrate this.
 Table 5. Relationship between behavioral changes and consumption of different treatments
Drugs Behavioral 
changes
positive 
symptoms
(n = 44)
negative 
symptoms
(n = 21)
positive and 
negative 
symptoms 
(n = 9)
total with 
behavioral 
changes 
(n = 56)
without any 
behavioral 
changes
(n = 5)
p (total 
behavioral 
change vs. no 
change)
Analgesics 12 (27.3%) 4 (20%) 2 (22.2%) 14 (25.5%) 6 (17.1%) 0.355
Anxiolytics 17 (38.6%) 6 (28.6%) 4 (44.4%) 19 (33.9%) 3 (8.6%) 0.006
Antidepressants 8 (18.2%) 4 (19.0%) 2 (22.2%) 10 (17.9%) 2 (5.7%) 0.096
Antiplatelets 3 (6.8%) 0 0 3 (5.4%) 7 (20.0%) 0.03
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 As previous literature shows that there is an increased risk of physical illness in care-
givers of patients with dementia, we consider it essential to extend the search for drugs that 
can be related to caregivers  [16, 32] . Delgado Parada et al.  [32] conducted a study which 
found that primary caregivers of patients with dementia use more antidepressants and anxio-
lytics than the general population. Van Houten et al.  [33] , on the other hand, only linked the 
consumption of psychotropic drugs with the number of hours dedicated to a patient, but not 
with the burden. However, the work of Roepke et al.  [16] demonstrates an association 
between cholesterol-lowering drugs and the status of caregivers of patients with dementia. 
In our case, although we could not detect statistical significance, we did find a positive trend 
towards the use of cholesterol-lowering drugs and the condition of caregivers because, as it 
has been shown, being a caregiver is related to endocrine-metabolic disturbances and an 
increased likelihood of having metabolic syndrome  [20] .
 We have also shown that there is a higher percentage of caregivers receiving nonphar-
macological treatment compared to noncaregivers. Various therapies have proven to be 
effective in reducing the burden of caregivers  [3, 34, 35] , the group therapies and specifically 
the cognitive behavioral therapy being most effective  [24, 36, 37] . In our case, 28.6% of the 
caregivers went to an association that offered a group therapy similar to cognitive behavioral 
therapy, 17.6% went to a psychologist and 16.5% received help from a social worker. In this 
regard, we have found that caregivers who use nonpharmacological support (associations 
and psychologists) take more anxiolytics, analgesics, antihypertensives and statins than 
those who do not use these aids, although statistical significance was not reached. This could 
be the result of the duration of time they have been on therapy and the fact that it is precisely 
the most burdened caregivers who come to the association. Group therapies have proven 
effective in the long term, and probably after months or years of therapy, caregivers will use 
less drugs, especially anxiolytics.
 We can also see that there is a significant difference between the number of individuals 
in the group of caregivers who are subjectively burdened and the control group, as other 
projects had also indicated before  [38, 39] . Increased burden has been linked to factors such 
as female sex, ageing, higher educational level, being institutionalized, the behavior of patients 
they care for, whether or not they have any geriatric syndrome (particularly urinary inconti-
nence), dependence in basic and instrumental activities for daily living, the degree of cognitive 
impairment of the patient, appraisal and social support  [9, 16, 19, 21, 35, 40–42] . Although 
our study did not focus on finding a relationship between burden and demographic variables, 
our caregiver profile (a burdened wife of 67–68 years of age with a low educational level and 
no job) corresponds largely to the standard caregiver profile shown by other authors  [4, 32, 
43, 44] that associates these variables with a greater degree of burden  [45–48] . Some studies 
talk about the effect of culture  [49] and religion  [50, 51] on caregivers, but we did not analyze 
these data, since 98.90% of our caregivers were Spanish and their religion, due to privacy 
reasons, was not requested.
 In our study, the degree of burden has been linked to drug consumption, finding statisti-
cally significant differences in the consumption of anxiolytics. This relationship has already 
been demonstrated by Pérodeau et al.  [52] and Delgado Parada et al.  [32] . Pérodeau et al.  [52] 
studied mental health and stress in patients who use psychotropics and those who do not, and 
they concluded that those who consumed psychotropics had a worse mental health and were 
under more stress. Meanwhile, Delgado Parada et al.  [32] linked analgesic consumption with 
the degree of the caregiver’s burden. However, despite finding differences in the consumption 
of these drugs between burdened and nonburdened caregivers, we have failed to find statis-
tical significance. Furthermore, behavioral changes have been linked to a higher level of 
burden  [53–58] . We have managed to find a trend between these changes and the analgesic 
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consumption in caregivers. Therefore, behavioral disturbances can be related not only to an 
increase in the caregiver’s burden, but also to an increased use of drugs by them.
 The small sample size is the main limitation of our study; it would be desirable to conduct 
new studies with a larger sample size in order to obtain greater statistical power. Unlike in 
the study by Clipp and George  [30] , we did not take into account the number of times the care-
givers go to a doctor as a parameter to assess their health. Finally, we should be aware that 
our study is subject to nonresponse bias.
 In conclusion, this study indicates that the use of drugs in general is an objective marker 
that shows the negative effects, in terms of a physical and psychological burden, of caring for 
patients with dementia. Due to the increasing prevalence of dementia in the population, it is 
important that the health system considers this issue, so it could take action to prevent that 
the caregivers become themselves patients. Other solutions, like cognitive behavioral ther-
apies or caregivers’ training courses, could reduce the use of psychotropic drugs in both the 
demented patients and caregivers, and should therefore be taken into account. 
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